INMB NASDAQ
INmune Bio, Inc.
1W: -5.0%
1M: -24.0%
3M: -10.1%
YTD: -1.3%
1Y: -20.0%
3Y: -79.0%
5Y: -91.7%
$1.52
+0.09 (+6.29%)
Weekly Expected Move ±6.7%
$1
$1
$1
$2
$2
Credit Risk of going bust: lower than 53% of companies Debt: 3.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.5%), INmune Bio, Inc. would be worth roughly what it owes.
Total debt $1.4M against a stock market value of $42.2M.
Distance to default 5.45 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $702K (short-term plus half of long-term), stock volatility 72.7%; Altman Z'' -23.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 99.5%), INmune Bio, Inc. would be worth roughly what it owes.
Total debt $1.4M against a stock market value of $42.2M.
Distance to default 5.45 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $702K (short-term plus half of long-term), stock volatility 72.7%; Altman Z'' -23.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships6
As Filer
counterparties named
1
As Counterparty
mentioned by others
1
Rel. Types
2021-09-15
Earliest Filing
2025-12-19
Latest Filing
partner: 6
Counterparties (Filed by INMB)
6 relationshipsCompanies named in INMB's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| A.G.P./Alliance Global Partners | — | partner | Sales agent for the offering of common stock | 2025-12-19 | View |
| Great Ormond Street Hospital NHS Foundation Trust | — | partner | Entered into a license agreement for exclusive commercial use of clinical trial data associated with the Mission EB stud | 2025-02-10 | View |
| BTIG, LLC | — | partner | Sales agent for the Company's At-The-Market stock offering | 2023-08-16 | View |
| Immune Ventures, LLC | — | partner | Exclusive license agreement partner for INKmune technology | 2023-04-20 | View |
| University of Pittsburgh | — | partner | Exclusive license agreement partner for licensed technology | 2023-04-20 | View |
| Crocker Mizner Park IV, Ltd. | — | partner | Landlord for lease agreement of 5,165 square feet in Boca Raton, Florida. | 2021-09-15 | View |
Mentioned As Counterparty
1 mentionsOther companies that named INMB in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-21 | Regulation FD; Other Events; Exhibits | View | |
| 2026-09-14 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-07-31 | Other Events; Exhibits | View | |
| 2026-07-01 | Material Agreement; Exhibits | Agreement | View |
| 2026-06-23 | Other Events; Exhibits | View | |
| 2026-06-17 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-06-02 | Other Events; Exhibits | View | |
| 2026-05-14 | Other Events; Exhibits | View | |
| 2026-05-05 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-02-27 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-23 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-19 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-01-27 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-23 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-12-19 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-12-10 | Termination of Material Definitive Agreement | View | |
| 2025-12-08 | Entry into Material Definitive Agreement; Material Modification to Rights of Security Holders; Finan | Agreement | View |
| 2025-12-05 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-03 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR